United States Recombinant Antibody Market Report & Forecast 2021-2027

Publisher Name :
Date: 13-Oct-2021
No. of pages: 94
Inquire Before Buying

United States Recombinant Antibody Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Recombinant Antibody Market Segment Percentages, By Type, 2020 (%)

- Chimeric Antibody

- Humanized Antibody

- Full Human Antibody

- Single Chain Antibody

- Bispecific Antibody

United States Recombinant Antibody Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Recombinant Antibody Market Segment Percentages, By Application, 2020 (%)

- Hospital

- Scientific Research

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Antibody revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Recombinant Antibody revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Abnova

- Medix Biochemica

- GE Healthcare

- SinoBiological

- Bioventix

United States Recombinant Antibody Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Recombinant Antibody Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Recombinant Antibody Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Recombinant Antibody Overall Market Size
2.1 United States Recombinant Antibody Market Size: 2021 VS 2027
2.2 United States Recombinant Antibody Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Antibody Players in United States Market
3.2 Top United States Recombinant Antibody Companies Ranked by Revenue
3.3 United States Recombinant Antibody Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Antibody Companies in United States Market, by Revenue in 2020
3.5 Companies Recombinant Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Antibody Players in United States Market
3.6.1 List of Tier 1 Recombinant Antibody Companies in United States
3.6.2 List of Tier 2 and Tier 3 Recombinant Antibody Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Recombinant Antibody Market Size Markets, 2021 & 2027
4.1.2 Chimeric Antibody
4.1.3 Humanized Antibody
4.1.4 Full Human Antibody
4.1.5 Single Chain Antibody
4.1.6 Bispecific Antibody
4.2 By Type - United States Recombinant Antibody Revenue & Forecasts
4.2.1 By Type - United States Recombinant Antibody Revenue, 2016-2021
4.2.2 By Type - United States Recombinant Antibody Revenue, 2022-2027
4.2.3 By Type - United States Recombinant Antibody Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Recombinant Antibody Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application - United States Recombinant Antibody Revenue & Forecasts
5.2.1 By Application - United States Recombinant Antibody Revenue, 2016-2021
5.2.2 By Application - United States Recombinant Antibody Revenue, 2022-2027
5.2.3 By Application - United States Recombinant Antibody Revenue Market Share, 2016-2027
6 Recombinant Antibody Companies Profiles
6.1 Abnova
6.1.1 Abnova Company Details
6.1.2 Abnova Business Overview
6.1.3 Abnova Recombinant Antibody Introduction
6.1.4 Abnova Recombinant Antibody Revenue in United States Market (2016-2021)
6.1.5 Abnova Recent Developments
6.2 Medix Biochemica
6.2.1 Medix Biochemica Company Details
6.2.2 Medix Biochemica Business Overview
6.2.3 Medix Biochemica Recombinant Antibody Introduction
6.2.4 Medix Biochemica Recombinant Antibody Revenue in United States Market (2016-2021)
6.2.5 Medix Biochemica Recent Developments
6.3 GE Healthcare
6.3.1 GE Healthcare Company Details
6.3.2 GE Healthcare Business Overview
6.3.3 GE Healthcare Recombinant Antibody Introduction
6.3.4 GE Healthcare Recombinant Antibody Revenue in United States Market (2016-2021)
6.3.5 GE Healthcare Recent Developments
6.4 SinoBiological
6.4.1 SinoBiological Company Details
6.4.2 SinoBiological Business Overview
6.4.3 SinoBiological Recombinant Antibody Introduction
6.4.4 SinoBiological Recombinant Antibody Revenue in United States Market (2016-2021)
6.4.5 SinoBiological Recent Developments
6.5 Bioventix
6.5.1 Bioventix Company Details
6.5.2 Bioventix Business Overview
6.5.3 Bioventix Recombinant Antibody Introduction
6.5.4 Bioventix Recombinant Antibody Revenue in United States Market (2016-2021)
6.5.5 Bioventix Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Recombinant Antibody Market Opportunities & Trends in United States Market
Table 2. Recombinant Antibody Market Drivers in United States Market
Table 3. Recombinant Antibody Market Restraints in United States Market
Table 4. Key Players of Recombinant Antibody in United States Market
Table 5. Top Recombinant Antibody Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Recombinant Antibody Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Recombinant Antibody Revenue Share by Companies, 2016-2021
Table 8. Companies Recombinant Antibody Product Type
Table 9. List of Tier 1 Recombinant Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Recombinant Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Recombinant Antibody Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Recombinant Antibody Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Recombinant Antibody Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Recombinant Antibody Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Recombinant Antibody Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Recombinant Antibody Revenue (US$, Mn), 2022-2027
Table 17. Abnova Company Details
Table 18. Abnova Business Overview
Table 19. Abnova Recombinant Antibody Product
Table 20. Abnova Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Abnova Recent Developments
Table 22. Medix Biochemica Company Details
Table 23. Medix Biochemica Business Overview
Table 24. Medix Biochemica Recombinant Antibody Product
Table 25. Medix Biochemica Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Medix Biochemica Recent Developments
Table 27. GE Healthcare Company Details
Table 28. GE Healthcare Business Overview
Table 29. GE Healthcare Recombinant Antibody Product
Table 30. GE Healthcare Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. GE Healthcare Recent Developments
Table 32. SinoBiological Company Details
Table 33. SinoBiological Business Overview
Table 34. SinoBiological Recombinant Antibody Product
Table 35. SinoBiological Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. SinoBiological Recent Developments
Table 37. Bioventix Company Details
Table 38. Bioventix Business Overview
Table 39. Bioventix Recombinant Antibody Product
Table 40. Bioventix Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Bioventix Recent Developments
List of Figures
Figure 1. Recombinant Antibody Segment by Type
Figure 2. Recombinant Antibody Segment by Application
Figure 3. United States Recombinant Antibody Market Overview: 2020
Figure 4. United States Recombinant Antibody Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Recombinant Antibody Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Recombinant Antibody Revenue in 2020
Figure 7. By Type - United States Recombinant Antibody Revenue Market Share, 2016-2027
Figure 8. By Application - United States Recombinant Antibody Revenue Market Share, 2016-2027
Figure 9. Abnova Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Medix Biochemica Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. GE Healthcare Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. SinoBiological Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Bioventix Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs